|
Health policy and outcome research
Citations 351-360 of 644 total displayed.
|
Past content
(since Jan 1999):
|
- Special Reports
A Device for Proximal Anastomosis of Autologous Coronary Vein Grafts: Report from the Meeting of the Circulatory System Devices Panel of the Food and Drug Administration Center for Devices and Radiologic Health
- William H. Maisel
Circulation 2005;112:1516-1518, doi:10.1161/CIRCULATIONAHA.105.569301
[Full text]
- Surgery for Coronary Artery Disease
Female Gender Is an Independent Predictor of Operative Mortality After Coronary Artery Bypass Graft Surgery: Contemporary Analysis of 31 Midwestern Hospitals
- Ron Blankstein, R. Parker Ward, Morton Arnsdorf, Barbara Jones, You-Bei Lou, and Michael Pine
Circulation 2005;112:I-323-327I-, doi:10.1161/CIRCULATIONAHA.104.525139
[Abstract]
[Full text]
- Health Services and Outcomes Research
Impact of the Pravastatin or Atorvastatin Evaluation and Infection TherapyThrombolysis In Myocardial Infarction 22/Reversal of Atherosclerosis With Aggressive Lipid Lowering Trials on Trends in Intensive Versus Moderate Statin Therapy in Ontario, Canada
- Peter C. Austin and Muhammad M. Mamdani
Circulation 2005;112:1296-1300; published online before print as doi:10.1161/CIRCULATIONAHA.104.531582
[Abstract]
[Full text]
- Editorials
Measuring Percutaneous Coronary Intervention Quality by Simple Case Volume
- Richard E. Kuntz and Sharon-Lise T. Normand
Circulation 2005;112:1088-1091, doi:10.1161/CIRCULATIONAHA.105.561126
[Full text]
- Articles
Impact of the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22/Reversal of Atherosclerosis With Aggressive Lipid Lowering Trials on Trends in Intensive Versus Moderate Statin Therapy in Ontario, Canada
- Peter C. Austin and Muhammad M. Mamdani
Circulation published August 22, 2005, doi:10.1161/CIRCULATIONAHA.104.531582
[Abstract]
- Correspondence
Letter Regarding Article by Nallamothu et al, "Times to Treatment in Transfer Patients Undergoing Primary Percutaneous Coronary Intervention in the United States" Response
- Bruce R. Brodie, Cindy L. Grines, Gregg W. Stone, Brahmajee K. Nallamothu, Eric R. Bates, Jeph Herrin, Yongfei Wang, Elizabeth H. Bradley, and Harlan M. Krumholz
Circulation 2005;112:e99-100e, doi:10.1161/CIRCULATIONAHA.105.551614
[Full text]
- Editorials
Effective Interventions to Reduce Smoking-Induced Heart Disease Around the World: Time to Act
- Joaquin Barnoya, Stella Aguinaga Bialous, and Stanton A. Glantz
Circulation 2005;112:456-458, doi:10.1161/CIRCULATIONAHA.105.554741
[Full text]
- Epidemiology
Role of Smoking in Global and Regional Cardiovascular Mortality
- Majid Ezzati, S. Jane Henley, Michael J. Thun, and Alan D. Lopez
Circulation 2005;112:489-497; published online before print as doi:10.1161/CIRCULATIONAHA.104.521708
[Abstract]
[Full text]
- Articles
Role of Smoking in Global and Regional Cardiovascular Mortality
- Majid Ezzati, S. Jane Henley, Michael J. Thun, and Alan D. Lopez
Circulation published July 18, 2005, doi:10.1161/CIRCULATIONAHA.104.521708
[Abstract]
- Valvular Heart Disease
Generic, Simple Risk Stratification Model for Heart Valve Surgery
- Gareth Ambler, Rumana Z. Omar, Patrick Royston, Robin Kinsman, Bruce E. Keogh, and Kenneth M. Taylor
Circulation 2005;112:224-231; published online before print as doi:10.1161/CIRCULATIONAHA.104.515049
[Abstract]
[Full text]
|
|